- Thompson Street Capital Partners, a private equity firm, has acquired Vector Laboratories, the Protein Detection business unit of Maravai Lifesciences Holdings Inc MRVI.
- The financial terms of the deal were not disclosed.
- Vector Laboratories manufactures labeling and visual detection reagents for life science researchers doing tissue-based protein detection and characterization.
- Price Action: MRVI shares closed 2.50% lower at $58.61 on Friday.
MRVIMaravai LifeSciences Holdings Inc
$2.451.24%
Edge Rankings
Momentum3.74
Growth89.72
Quality-
Value40.69
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
